Form 8-K - Current report:
SEC Accession No. 0001437749-24-029998
Filing Date
2024-09-25
Accepted
2024-09-25 17:21:09
Documents
19
Period of Report
2024-09-25
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K govx20240924_8k.htm   iXBRL 8-K 32286
2 EXHIBIT 5.1 ex_727126.htm EX-5.1 13460
3 EXHIBIT 10.1 ex_727127.htm EX-10.1 240274
8 l01.jpg GRAPHIC 5379
9 l02.jpg GRAPHIC 25307
10 logo.jpg GRAPHIC 24465
  Complete submission text file 0001437749-24-029998.txt   575742

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA govx-20240925.xsd EX-101.SCH 3891
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE govx-20240925_def.xml EX-101.DEF 13826
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE govx-20240925_lab.xml EX-101.LAB 18218
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE govx-20240925_pre.xml EX-101.PRE 13858
21 EXTRACTED XBRL INSTANCE DOCUMENT govx20240924_8k_htm.xml XML 4881
Mailing Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA GA 30080
Business Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA GA 30080 678-384-7220
GeoVax Labs, Inc. (Filer) CIK: 0000832489 (see all company filings)

EIN.: 870455038 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39563 | Film No.: 241325486
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)